Shuichi Hanada
Kagoshima, 8920853, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma.
Journal: Scientific reports
Published: November 15, 2024
A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan.
Journal: Leukemia & lymphoma
Published: February 11, 2023
Identification of putative noncanonical driver mutations in patients with essential thrombocythemia.
Identification of putative noncanonical driver mutations in patients with essential thrombocythemia.
Journal: European journal of haematology
Published: October 28, 2022
Central hepatectomy for hepatocellular carcinoma in a patient with anti-Gerbich antibody.
Journal: Surgical case reports
Published: April 01, 2020
Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.
Journal: Human vaccines & immunotherapeutics
Published: September 20, 2018
Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.
Journal: Leukemia & lymphoma
Published: May 17, 2017
Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.
Journal: British journal of haematology
Published: April 04, 2017
Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.
Journal: Blood
Published: December 31, 2016
Acute Myeloid Leukemia Diagnosed 5 Years after Adult T-Cell Leukemia/Lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 25, 2015
Spontaneous regression of essential thrombocythemia with MPL mutation on menopause.
Journal: International journal of hematology
Published: November 28, 2013
Last Updated: 09/26/2026